FIELD: medicine, oncology.
SUBSTANCE: invention relates to a method for treatment of malignant tumors. Method involves administration in a patient the chemotherapeutically active dose of antitumor platinum compound, foe example, cisplatin or carboplatin and erythropoietin or erythropoietin-like substance wherein the latter is administrated before administration of platinum compound or simultaneously with its. This method provides attaining the synergistic antitumor effect.
EFFECT: improved and valuable medicinal effect.
8 cl, 2 tbl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED APPLICATION OF ECTEINASCIDIN-743 AND PLATINUM-CONTAINING ANTI-TUMOUR COMPOUNDS | 2004 |
|
RU2391101C2 |
| PLATINUM NANOCOMPOUNDS AND METHODS OF APPLYING THEREOF | 2010 |
|
RU2538199C2 |
| COMBINED ANTICANCER THERAPY AND PHARMACEUTICAL COMPOSITIONS THEREFOR | 2005 |
|
RU2396960C2 |
| DIAGNOSTICS AND TREATMENT OF CANCER ASSOCIATED WITH CANCER STEM CELLS | 2014 |
|
RU2749867C2 |
| COMBINED THERAPY WITH EZH2 INHIBITOR | 2018 |
|
RU2754131C1 |
| COMPOSITION CONTAINING PIC FOR CANCER TREATMENT | 2017 |
|
RU2728175C2 |
| COMPOUND ANTAGONIST VEGF AND ANTIPROLIFERATIVE AGENT | 2004 |
|
RU2353353C2 |
| COMPOSITION FOR PREPARATION OF ANTI-TUMOR MEDICATION AND METHOD FOR PREPARATION OF ANTI-TUMOR MEDICATION BASED ON IT | 2016 |
|
RU2667128C2 |
| COMBINED THERAPY BY USING PENTAFLUOROBENZENE SULFONAMIDES | 2000 |
|
RU2268054C2 |
| PHARMACEUTICAL COMBINATION FOR TREATMENT AND/OR CHEMOSENSITISATION OF TUMOURS RESISTANT TO ANTICANCER DRUGS | 2007 |
|
RU2396974C2 |
